FI934690A0 - En organspecifik emulsion - Google Patents

En organspecifik emulsion

Info

Publication number
FI934690A0
FI934690A0 FI934690A FI934690A FI934690A0 FI 934690 A0 FI934690 A0 FI 934690A0 FI 934690 A FI934690 A FI 934690A FI 934690 A FI934690 A FI 934690A FI 934690 A0 FI934690 A0 FI 934690A0
Authority
FI
Finland
Prior art keywords
emulsion
pct
cyclopenta
phenanthrene
emulsions
Prior art date
Application number
FI934690A
Other languages
English (en)
Other versions
FI934690A (fi
Inventor
Bjoern Norrlind
Arvid Wretlind
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of FI934690A publication Critical patent/FI934690A/fi
Publication of FI934690A0 publication Critical patent/FI934690A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Transceivers (AREA)
FI934690A 1991-04-23 1993-10-22 En organspecifik emulsion FI934690A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9101214A SE470086B (sv) 1991-04-23 1991-04-23 Organspecifik emulsion
PCT/SE1992/000261 WO1992018169A1 (en) 1991-04-23 1992-04-22 An organ specific emulsion

Publications (2)

Publication Number Publication Date
FI934690A FI934690A (fi) 1993-10-22
FI934690A0 true FI934690A0 (fi) 1993-10-22

Family

ID=20382533

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934690A FI934690A0 (fi) 1991-04-23 1993-10-22 En organspecifik emulsion

Country Status (19)

Country Link
US (1) US5445811A (fi)
EP (1) EP0581842B1 (fi)
JP (1) JPH06506932A (fi)
AT (1) ATE181241T1 (fi)
AU (1) AU660974B2 (fi)
CA (1) CA2109094A1 (fi)
DE (1) DE69229441D1 (fi)
DK (1) DK0581842T3 (fi)
ES (1) ES2135405T3 (fi)
FI (1) FI934690A0 (fi)
GR (1) GR3031053T3 (fi)
HU (1) HU210577B (fi)
IE (1) IE921289A1 (fi)
NO (1) NO307449B1 (fi)
NZ (1) NZ242436A (fi)
PT (1) PT100418B (fi)
SE (1) SE470086B (fi)
WO (1) WO1992018169A1 (fi)
ZA (1) ZA922930B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
DK0605477T4 (da) * 1991-09-17 2007-10-01 Ge Healthcare As Gasformige ultralydskontrastmidler
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
PL176116B1 (pl) * 1993-01-25 1999-04-30 Sonus Pharma Inc Środek kontrastowy do ultrasonografii i sposób wytwarzania środka kontrastowego do ultrasonografii
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
US6423363B1 (en) * 1997-08-22 2002-07-23 Lipton, Division Of Conopco, Inc. Aqueous dispersion
EP1121088B1 (de) * 1998-10-14 2002-12-18 Cognis Deutschland GmbH & Co. KG Verwendung von nanoskaligen sterolen und sterolestern
US6274574B1 (en) 1999-02-26 2001-08-14 Kraft Foods, Inc. Use of mesophase-stabilized compositions for delivery of cholesterol-reducing sterols and stanols in food products
AU2003226031A1 (en) * 2002-04-10 2003-10-27 Thomas P Binder Hydrothermically processed compositions containing phytosterols
US7306819B2 (en) * 2002-06-12 2007-12-11 The Coca-Cola Company Beverages containing plant sterols
EP1651276A4 (en) * 2003-08-08 2009-05-06 Barnes Jewish Hospital EMULSION PARTICLES FOR IMAGING AND THERAPY AND USE METHOD THEREFOR
EP1682154B1 (en) * 2003-10-24 2010-08-04 The Coca-Cola Company Process for preparing phytosterol dispersions for application in beverages
CH712511B1 (de) * 2006-09-18 2017-11-30 Forim-X Ag C/O Prof Dr Med Richard Dirnhofer Röntgenkontrastmittel für die postmortale, experimentelle und diagnostische Angiographie.
US8367041B2 (en) 2006-09-18 2013-02-05 Forim-X Ag Radiographic contrast agent for postmortem, experimental and diagnostic angiography
FR3039767B1 (fr) 2015-08-04 2017-09-08 Guerbet Sa Composition destinee a vectoriser un agent anticancereux
US20220151886A1 (en) * 2019-04-01 2022-05-19 Conopco, Inc., D/B/A Unilever Multiple emulsion comprising an oil continuous nanoemulsion and a method for using the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB676738A (en) * 1949-11-16 1952-07-30 Bayer Ag Parenterally administrable x-ray contrast agents
GB721264A (en) * 1952-10-13 1955-01-05 Astra Apotekarnes Kem Fab Improvements relating to contrast preparations for visualising the vascular system by x-ray
US3356575A (en) * 1965-04-13 1967-12-05 Leo Ab Autosterile injectable iodinated oil X-ray contrast medium
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
US4404182A (en) * 1980-01-08 1983-09-13 The United States Of America As Represented By The Department Of Health And Human Services Ethiodized oil emulsion for intravenous hepatography
GB2156345B (en) * 1984-03-30 1987-07-08 Squibb & Sons Inc Alkylamine salts of 3,5-diacetylamino-2,4,6-triiodobenzoic acid as x-ray contrast agents
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
CH672733A5 (fi) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
ES2054706T3 (es) * 1987-06-11 1994-08-16 Kabi Pharmacia Ab Emulsion que contiene yodo.
GB8900376D0 (en) * 1989-01-09 1989-03-08 Nycomed As Iodinated esters
AU642066B2 (en) * 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
DE4111939A1 (de) * 1991-04-12 1992-10-22 Fresenius Ag Parenteral verabreichbare, hitzesterilisierbare o/w-emulsion eines roentgenkontrastmittels
SE9101709L (sv) * 1991-06-03 1992-12-04 Karlshamns Lipidteknik Ab Lipidderivat som diagnostikum eller kontrastmedel
US5318768A (en) * 1992-05-01 1994-06-07 Sterling Winthrop Inc. Polymeric x-ray contrast compositions containing an organic crystalline x-ray contrast agent

Also Published As

Publication number Publication date
AU1680592A (en) 1992-11-17
IE921289A1 (en) 1992-11-04
US5445811A (en) 1995-08-29
PT100418B (pt) 1999-08-31
HU9303005D0 (en) 1994-01-28
SE9101214D0 (sv) 1991-04-23
JPH06506932A (ja) 1994-08-04
EP0581842A1 (en) 1994-02-09
ES2135405T3 (es) 1999-11-01
PT100418A (pt) 1993-08-31
ATE181241T1 (de) 1999-07-15
DK0581842T3 (da) 1999-11-22
DE69229441D1 (de) 1999-07-22
NO933807L (no) 1993-10-22
FI934690A (fi) 1993-10-22
GR3031053T3 (en) 1999-12-31
HUT65882A (en) 1994-07-28
SE470086B (sv) 1993-11-08
AU660974B2 (en) 1995-07-13
HU210577B (en) 1995-05-29
SE9101214L (sv) 1992-10-24
WO1992018169A1 (en) 1992-10-29
NZ242436A (en) 1994-03-25
NO307449B1 (no) 2000-04-10
ZA922930B (en) 1994-10-07
CA2109094A1 (en) 1992-10-24
EP0581842B1 (en) 1999-06-16

Similar Documents

Publication Publication Date Title
FI934690A (fi) En organspecifik emulsion
US5985177A (en) O/W/O type multiple emulsion and method of preparing the same
Baron et al. Thymic cysts following radiation therapy for Hodgkin disease.
Weingarten et al. Interactions of a non-ionic ABA copolymer surfactant with phospholipid monolayers: possible relevance to emulsion stabilization
KR830000911A (ko) X-선 콘트라스트제제의 살균된 주사용의 생리적으로 가능한 용액의 제조방법 및 x-선콘트라스트 제제 및 완충액
Baekey et al. Grapefruit pectin inhibits hypercholesterolemia and atherosclerosis in miniature swine
Lippold et al. Comparison of the Wechsler Adult Intelligence Scale and the Wechsler Adult Intelligence Scale-Revised.
JPS5716818A (en) Steroid fatty emulsion
Skanse et al. The effect of corticotrophin and cortisone on serum lipids and lipoproteins
Bricker et al. Autonomous cholesterol and fatty acid synthesis in hepatomas: Deletion of the adenosine 3′, 5′-cyclic monophosphate control mechanism of normal liver
JP2930730B2 (ja) 酸又は塩基加水分解を受ける活性成分を含有する緩衝されたエマルジョン組成物
Combes et al. The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis
Hendrickx et al. Thymic atrophy and rebound enlargement following chemotherapy for testicular cancer
Pritchard et al. Alpha feto (αFP) monitoring of response to adriamycin in hepatoblastoma
Miller et al. Various applications of corpus cavernosography
Rubens et al. Norethisterone acetate in the treatment of advanced breast cancer
JPH10101520A (ja) 皮膚外用剤
Ayyad et al. Hormonal control of cholesterol cholelithiasis in the female hamster
Garrigues et al. Absorption-partition relationships for true homologous series of xenobiotics as a possible approach to study mechanisms of surfactants in absorption. IV. Phenylacetic acid derivatives and anionic surfactants
JP2001163777A (ja) 皮膚外用液剤
JP2004238334A (ja) 皮膚外用剤
Kerth et al. Flow and composition of cardiac lymph in dogs
Harper et al. DROPERIDOL PREMEDICATION
Burgener et al. Retrograde Hepatography and Indirect Lymphography of the Liver: An Experimental Study in the Dog
Grinsztejn et al. Isolation of Mycobacteria from Blood of AIDS Patients in Brazil: A Prospective Study

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA AB